Drug    DrugBank | All Description Patterns💬 Info on mouse-over

No.	Drug (Description in trials)	DrugBank	KEGG DRUG	KEGG GENES	KEGG PATHWAY On map, Yellow: Drug target genes	Disease ID
1	10 milligram (mg) fampridine-sr (4-aminopyridine, 4-ap)	Dalfampridine	[1] D04127 💬	[4] KCNA4, KCNC3, KCND2, KCND3 💬	[4] Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia	[1] 13 💬
2	15 mg fampridine-sr (4-aminopyridine, 4-ap)	Dalfampridine	[1] D04127 💬	[4] KCNA4, KCNC3, KCND2, KCND3 💬	[4] Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia	[1] 13 💬
3	20 mg fampridine-sr (4-aminopyridine, 4-ap)	Dalfampridine	[1] D04127 💬	[4] KCNA4, KCNC3, KCND2, KCND3 💬	[4] Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia	[1] 13 💬
4	Biib041 (fampridine)	Dalfampridine	[1] D04127 💬	[4] KCNA4, KCNC3, KCND2, KCND3 💬	[4] Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia	[1] 13 💬
5	Biib041 (fampridine-sr)	Dalfampridine	[1] D04127 💬	[4] KCNA4, KCNC3, KCND2, KCND3 💬	[4] Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia	[1] 13 💬
6	Biib041 (pr fampridine)	Dalfampridine	[1] D04127 💬	[4] KCNA4, KCNC3, KCND2, KCND3 💬	[4] Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia	[1] 13 💬
7	Dalfampridine	Dalfampridine	[1] D04127 💬	[4] KCNA4, KCNC3, KCND2, KCND3 💬	[4] Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia	[2]  4 , 13 💬
8	Dalfampridine er	Dalfampridine	[1] D04127 💬	[4] KCNA4, KCNC3, KCND2, KCND3 💬	[4] Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia	[1] 13 💬
9	Dalfampridine-er 10mg	Dalfampridine	[1] D04127 💬	[4] KCNA4, KCNC3, KCND2, KCND3 💬	[4] Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia	[1] 13 💬
10	Dalfampridine-er 5mg	Dalfampridine	[1] D04127 💬	[4] KCNA4, KCNC3, KCND2, KCND3 💬	[4] Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia	[1] 13 💬
11	Extended release fampridine	Dalfampridine	[1] D04127 💬	[4] KCNA4, KCNC3, KCND2, KCND3 💬	[4] Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia	[1] 13 💬
12	Fampridine	Dalfampridine	[1] D04127 💬	[4] KCNA4, KCNC3, KCND2, KCND3 💬	[4] Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia	[2] 13, 14 💬
13	Fampridine sr	Dalfampridine	[1] D04127 💬	[4] KCNA4, KCNC3, KCND2, KCND3 💬	[4] Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia	[1] 13 💬
14	Fampridine-sr	Dalfampridine	[1] D04127 💬	[4] KCNA4, KCNC3, KCND2, KCND3 💬	[4] Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia	[1] 13 💬
15	Fampridine-sr b.i.d. (twice daily)	Dalfampridine	[1] D04127 💬	[4] KCNA4, KCNC3, KCND2, KCND3 💬	[4] Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia	[1] 13 💬
16	Other: withdrawal of dalfampridine-er 10mg	Dalfampridine	[1] D04127 💬	[4] KCNA4, KCNC3, KCND2, KCND3 💬	[4] Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia	[1] 13 💬
17	Prolonged-release fampridine	Dalfampridine	[1] D04127 💬	[4] KCNA4, KCNC3, KCND2, KCND3 💬	[4] Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia	[1] 13 💬
18	Sr-fampridine	Dalfampridine	[1] D04127 💬	[4] KCNA4, KCNC3, KCND2, KCND3 💬	[4] Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia	[1] 13 💬
19	Sustained-release oral dalfampridine	Dalfampridine	[1] D04127 💬	[4] KCNA4, KCNC3, KCND2, KCND3 💬	[4] Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia	[1] 13 💬